ArticleCardiovascular diabetology2024

SGLT2 inhibitor downregulates ANGPTL4 to mitigate pathological aging of cardiomyocytes induced by type 2 diabetes.

Yun Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.